Common Adverse Effects

Interactions for Pemirolast Potassium

Pemirolast Potassium Pharmacokinetics

Absorption

Bioavailability

Following topical application to both eyes (0.1% solution 4 times daily for 2 weeks), peak plasma concentrations were attained within about 25 minutes, but were substantially lower than those following a single (10 mg) oral dose.1

Advice to Patients

Importance of learning and adhering to proper administration techniques to avoid contamination of the product.1

Importance of removing soft contact lenses prior to administration of each dose.1 Delay reinsertion for 10 minutes after administration if eyes are not red; do not wear contact lenses if eye(s) are red.1 Not indicated for contact lens-related irritation.1

Importance of reporting any worsening of symptoms or new-onset ocular pain/discomfort.8

Importance of women informing clinicians if they are or plan to become pregnant or plan to breast-feed.1

Importance of informing patients of other important precautionary information.1 (See Cautions.)

Preparations

Excipients in commercially available drug preparations may have clinically important effects in some individuals; consult specific product labeling for details.